While MPZL3 remains a protein of relatively unknown function, determining its mechanism in energy homeostasis will facilitate development of pharmacological approaches to target obesity and related comorbid conditions. Here, MPZL3 is linked to obesity due to melanocortin 4 receptor deficiency.